Welcome To AspenBio Pharma

AspenBio Pharma, Inc. (NASDAQ: APPY) is developing AppyScore™ — a novel, rapid, blood-based diagnostic test to assist physicians in the difficult challenge of evaluating acute appendicitis. AppyScore could play an important role in reducing healthcare costs and patient exposure to harmful radiation from CT scanning.

Latest News

Click a Press Release headline below to view that item in a new window.